G1 Therapeutics, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D amendment with the SEC on 2016-07-01. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Frederic N Eshelman | Director | RESEARCH TRIANGLE PARK, NC |
| Peter A Kolchinsky | Director | Seattle, WA |
| Ron A Laufer | Director | RESEARCH TRIANGLE PARK, NC |
| Glenn A Muir | Director | RESEARCH TRIANGLE PARK, NC |
| SETH A RUDNICK | Director | MORRISVILLE, NC |
| Christy A Shaffer | Director | Durham, NC |
| Timothy N Sullivan | Director | RESEARCH TRIANGLE PARK, NC |
| Mark A Velleca | Director | RESEARCH TRIANGLE PARK, NC |
| Gregory N Mossinghoff | Executive Officer | RESEARCH TRIANGLE PARK, NC |
| Mark A Velleca | Executive Officer | RESEARCH TRIANGLE PARK, NC |
| Clay Thorp | Director | Durham, NC |
| Christy Shaffer | Director | Durham, NC |
| Norman Sharpless | Director | Palo Alto, CA |
| Carol Webb | Director | Cranford, NJ |
| Carol A Webb | Director | Research Triangle Park, NC |
| Clay A Thorp | Director | Research Triangle Park, NC |
| Michael A Gutch | Director | Research Triangle Park, NC |
| Norman A Sharpless | Director | Research Triangle Park, NC |
| Gregory A Mossinghoff | Executive Officer | Research Triangle Park, NC |
| Ron K Laufer | Director | Research Triangle Park, NC |
| Michael K Gutch | Director | Research Triangle Park, NC |
| Thomas K Laundon | Executive Officer | Research Triangle Park, NC |
| Jay K Strum | Executive Officer | Research Triangle Park, NC |
| Seth K Rudnick | Director | Research Triangle Park, NC |
| Jay Strum | Director | Chapel Hill, NC |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2016-05-11 | D | $50.0M | $47.0M |
| 2015-02-12 | D | $33.0M | $16.5M |
| 2014-06-23 | D/A | $12.6M | $12.6M |
| 2013-10-17 | D | $12.6M | $6.3M |
| 2013-08-23 | D/A | $1.3M | $1.2M |
| 2013-04-18 | D | $1.0M | $458K |
| 2012-10-12 | D | $763K | $763K |